Zhang Yi, Mo Fangfang, Zhang Dongwei, Gao Sihua, Zhao Dandan, Yu Na, Mu Qianqian, Zuo Jiacheng, Ma Yue
Institute of Traditional Chinese Medicine Health Management, Beijing Open University, Beijing 100081, China.
Diabetes Research Center, Beijing University of Chinese Medicine, Beijing 100029, China.
J Tradit Chin Med. 2018 Aug;38(4):570-578.
To observe the effect of Jiangtang Xiaoke (JTXK) granule on endoplasmic reticulum (ER) stress in high fat diet (HFD)-induced type 2 diabetes mellitus (T2DM) KK-Ay mice.
KK-Ay mice were fed with HFD to induce the T2DM model, while normal control C57BL/6J mice were given standard feed. Fasting blood glucose (FBG) in all mice was measured weekly and oral glucose tolerance tests (OGTTs) were performed at 4 and 10 weeks after start of treatment to determine glucose metabolism. Serum fasting insulin (FINS) and insulin sensitivity index (ISI) were measured to determine insulin sensitivity. mRNA expressions of eukaryotic initiation factor-2 alpha (eIF2¦Á), glucose regulated protein 78 (GRP78), activating transcription factor 4 (ATF4), and C/EBP homology protein (CHOP) were assessed by reverse transcription polymerase chain reaction and the protein expressions of p-eIF2¦Á, GRP78, and CHOP were assessed by Western blotting.
JTXK granule significantly reduced FBG and free fatty acid levels and improved OGTT at the 120 min of the 10-week treatment in T2DM KK-Ay mice. FINS and HbAlc levels were reduced and insulin sensitivities were increased in KK-Ay diabetic mice, which were improved with the treatment of JTXK granule, especially at the 7 and 3.5 g/kg doses. JTXK granule at the 3.5 g/kg dose was most effective in reducing both gene and protein expressions of eIF2¦Á, GRP78, and CHOP.
ER stress response is increased in T2DM KK-Ay mice. Treatment with JTXK granule attenuates glucose disorders, improves insulin sensitivity, and reduces serum FFA in T2DM KK-Ay mice. The mechanisms may be attributed to regulation of the signaling ER stress pathway via decreasing eIF2¦Á phosphorylation and suppressing eIF2¦Á- ATF4-CHOP activation.
观察降糖消颗(JTXK)粒对高脂饮食(HFD)诱导的2型糖尿病(T2DM)KK-Ay小鼠内质网(ER)应激的影响。
用HFD喂养KK-Ay小鼠以诱导T2DM模型,而正常对照C57BL/6J小鼠给予标准饲料。每周测量所有小鼠的空腹血糖(FBG),并在治疗开始后4周和10周进行口服葡萄糖耐量试验(OGTT)以确定葡萄糖代谢。测量血清空腹胰岛素(FINS)和胰岛素敏感性指数(ISI)以确定胰岛素敏感性。通过逆转录聚合酶链反应评估真核起始因子-2α(eIF2α)、葡萄糖调节蛋白78(GRP78)、激活转录因子4(ATF4)和C/EBP同源蛋白(CHOP)的mRNA表达,并通过蛋白质印迹法评估p-eIF2α、GRP78和CHOP的蛋白表达。
在10周治疗的第120分钟,JTXK颗粒显著降低了T2DM KK-Ay小鼠的FBG和游离脂肪酸水平,并改善了OGTT。KK-Ay糖尿病小鼠的FINS和糖化血红蛋白(HbAlc)水平降低,胰岛素敏感性增加,用JTXK颗粒治疗后有所改善,尤其是在7和3.五岁时。5 g/kg剂量。3.5 g/kg剂量的JTXK颗粒在降低eIF2α、GRP78和CHOP的基因和蛋白表达方面最有效。
T2DM KK-Ay小鼠的内质网应激反应增加。JTXK颗粒治疗可减轻T2DM KK-Ay小鼠的葡萄糖紊乱,提高胰岛素敏感性,并降低血清游离脂肪酸。其机制可能归因于通过降低eIF2α磷酸化和抑制eIF2α-ATF4-CHOP激活来调节内质网应激信号通路。